| 6MWT | 6 min walking test |
| ABC | approximate Bayesian computation model |
| AE | adverse event |
| CI | confidence interval |
| OPD | infantile-onset Pompe disease |
| ERT | enzyme replacement therapy |
| FVC | forced vital capacity |
| GAA | acid alpha-glucosidase |
| GLMM | generalized linear mixed model |
| IAR | infusion-associated reaction |
| IgG | immunoglobulin G |
| IR | incidence rate |
| LOPD | late-onset Pompe disease |
| LOTS | late-onset treatment study |
| ML | maximum likelihood |
| MRC | Medical Research Council |
| NB | newborn |
| NRSI | non-randomized studies of interventions |
| PD | Pompe disease |
| PedsQL | Pediatric Quality of Life Inventory™ |
| PICO | patients, intervention, control, outcome |
| QOL | quality of life |
| RCT | randomized clinical trial |
| REML | restricted maximum-likelihood estimator |
| RoB | Risk of Bias tool |
| ROBINS-I | Risk Of Bias In Non-randomized Studies of Interventions tool |
| SM | Supplementary Materials |
| TOV | time on ventilatory support |
| WGMS | Walton and Gardner-Medwin Scale |